Literature DB >> 23650170

Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012.

Roger Dumke, Christian Lück, Enno Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23650170      PMCID： PMC3697311          DOI： 10.1128/AAC.00706-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists.

Authors:  E Jacobs
Journal:  Euro Surveill       Date:  2012-02-09

2.  Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.

Authors:  S A Uldum; J M Bangsborg; B Gahrn-Hansen; R Ljung; M Mølvadgaard; R Føns Petersen; C Wiid Svarrer
Journal:  Euro Surveill       Date:  2012-02-02

3.  Management of macrolide-resistant Mycoplasma pneumoniae infection.

Authors:  Veroniek Saegeman; Marijke Proesmans; Roger Dumke
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

4.  Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

5.  Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

Authors:  R Dumke; H von Baum; P C Lück; E Jacobs
Journal:  Clin Microbiol Infect       Date:  2009-09-17       Impact factor: 8.067

6.  The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.

Authors:  S Pereyre; A Touati; J Petitjean-Lecherbonnier; A Charron; A Vabret; C Bébéar
Journal:  Clin Microbiol Infect       Date:  2012-12-22       Impact factor: 8.067

7.  Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.

Authors:  Masaki Yamada; Richard Buller; Stephanie Bledsoe; Gregory A Storch
Journal:  Pediatr Infect Dis J       Date:  2012-04       Impact factor: 2.129

8.  Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

Authors:  Fei Zhao; Gang Liu; Jiang Wu; Bin Cao; Xiaoxia Tao; Lihua He; Fanliang Meng; Liang Zhu; Min Lv; Yudong Yin; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

Review 9.  Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections.

Authors:  Thomas Prescott Atkinson; Mitchell F Balish; Ken B Waites
Journal:  FEMS Microbiol Rev       Date:  2008-08-27       Impact factor: 16.408

10.  The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel.

Authors:  Sabine Pereyre; Alain Charron; Carlos Hidalgo-Grass; Arabella Touati; Allon E Moses; Ran Nir-Paz; Cécile Bébéar
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240
View more
  9 in total

1.  Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany.

Authors:  Roger Dumke; Thomas Ziegler
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.

Authors:  Ken B Waites; Donna M Crabb; Lynn B Duffy; Jorgen S Jensen; Yang Liu; Susanne Paukner
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.

Authors:  Zibo Zhou; Xiangzhi Li; Xiaojian Chen; Fangjun Luo; Changwang Pan; Xiaoping Zheng; Feng Tan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

Review 5.  The role of the PM2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae infections: a systematic review.

Authors:  Wei Hou; Xijin Xu; Yongge Lei; Junjun Cao; Yu Zhang; Liang Chen; Xia Huo
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-04       Impact factor: 4.223

Review 6.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

7.  No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.

Authors:  Karolina Gullsby; Kåre Bondeson
Journal:  Infect Ecol Epidemiol       Date:  2016-06-01

Review 8.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640

9.  Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.

Authors:  Michael L Beeton; Xu-Sheng Zhang; Søren A Uldum; Cécile Bébéar; Roger Dumke; Karolina Gullsby; Margareta Ieven; Katherine Loens; Ran Nir-Paz; Sabine Pereyre; O Brad Spiller; Victoria J Chalker
Journal:  Euro Surveill       Date:  2020-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.